Babnigg G, Sherrell D, Kim Y, Johnson JL, Nocek B, Tan K, Axford D, Li H, Bigelow L, Welk L, Endres M, Owen RL, Joachimiak A (2022) <br />Data collection from crystals grown in microfluidic droplets<br /><i>Acta Crystallographica D Struct Biol</i> <b>78</b>: 997<br /><br />Johnson JL, Huang J, Rooney M, Gu C (2021) <br />Optimal pH 8.5 to 9 for the Hydrolysis of Vixotrigine and Other Basic Substrates of Carboxylesterase-1 in Human Liver Microsomes<br /><i>Xenobiotica</i> <br /><br />Venkatasubban KS, Johnson JL, Thomas JL, Fauq A, Cusack B, Rosenberry TL (2018) <br />Decarbamoylation of acetylcholinesterases is markedly slowed as carbamoyl groups increase in size<br /><i>Archives of Biochemistry & Biophysics</i> <b>655</b>: 67<br /><br />Johnson JL, Shi Y, Snipes R, Janmohamed S, Rolfe TE, Davis B, Postle A, Macphee CH (2014) <br />Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial<br /><i>PLoS ONE</i> <b>9</b>: e89034<br /><br />Berger JS, Ballantyne CM, Davidson MH, Johnson JL, Tarka EA, Lawrence D, Trivedi T, Zalewski A, Mohler ER, 3rd (2011) <br />Peripheral artery disease, biomarkers, and darapladib<br /><i>American Heart Journal</i> <b>161</b>: 972<br /><br />Auletta JT, Johnson JL, Rosenberry TL (2010) <br />Molecular basis of inhibition of substrate hydrolysis by a ligand bound to the peripheral site of acetylcholinesterase<br /><i>Chemico-Biological Interactions</i> <b>187</b>: 135<br /><br />Mohler ER, 3rd, Ballantyne CM, Davidson MH, Hanefeld M, Ruilope LM, Johnson JL, Zalewski A (2008) <br />The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study<br /><i>J Am Coll Cardiol</i> <b>51</b>: 1632<br /><br />Rosenberry TL, Sonoda LK, Dekat SE, Cusack B, Johnson JL (2008) <br />Monitoring the reaction of carbachol with acetylcholinesterase by thioflavin T fluorescence and acetylthiocholine hydrolysis<br /><i>Chemico-Biological Interactions</i> <b>175</b>: 235<br /><br />Rosenberry TL, Sonoda LK, Dekat SE, Cusack B, Johnson JL (2008) <br />Analysis of the reaction of carbachol with acetylcholinesterase using thioflavin T as a coupled fluorescence reporter<br /><i>Biochemistry</i> <b>47</b>: 13056<br /><br />Cusack B, Romanovskis P, Johnson JL, Etienne G, Rosenberry TL (2005) <br />A novel strategy for protection against organophosphate toxicity: Evolution of cyclic inhibitors with high affinity for the acetylcholinesterase peripheral site<br /><i>Chemico-Biological Interactions</i> <b>157-158</b>: 370<br /><br />Rosenberry TL, Johnson JL, Cusack B, Thomas JL, Emani S, Venkatasubban KS (2005) <br />Interactions between the peripheral site and the acylation site in acetylcholinesterase<br /><i>Chemico-Biological Interactions</i> <b>157-158</b>: 181<br /><br />Cusack B, Johnson JL, Hughes TF, McCullough EH, Fauq A, Romanovskis PV, Spatola AF, Rosenberry TL (2004) <br />Tethering of ligands near the active site of acetylcholinesterase mutant H287C: Progress on a new strategy for protection against organophosphate inactivation<br /><i>In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects</i> <b> (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina</b>: 259 <br /><br />Cusack B, Johnson JL, Hughes TF, McCullough EH, Romanovskis PV, Spatola AF, Rosenberry TL (2004) <br />Poster (76) Modulation of acetylcholinesterase kinetics employing ligands tethered to the mutant H287C: a model for organophosphate inhibitor desin<br /><i>In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects</i> <b> (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina</b>: 360<br /><br />Johnson JL, Cusack B, Davies MP, Fauq A, Rosenberry TL (2004) <br />Substrate activation with a cationic acetanilide substrate in human acetylcholinesterase<br /><i>In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects</i> <b> (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina</b>: 213 <br /><br />Johnson JL, Cusack B, Davies MP, Rosenberry TL (2004) <br />Poster (16) Ligand interactions within the active site of acetylcholinesterase<br /><i>In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects</i> <b> (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina</b>: 328<br /><br />Johnson JL, Cusack B, Davies MP, Rosenberry TL (2004) <br />Poster (87) Ligand interactions within the active site of acetylcholinesterase<br /><i>In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects</i> <b> (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina</b>: 366<br /><br />Kovach IM, Viragh C, Reddy PM, Massiah MA, Mildvan AS, Johnson JL, Rosenberry TL (2004) <br />Poster (17) Short, strong hydrogen bonds at the active site of cholinesterases: H-NMR studies.<br /><i>In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects</i> <b> (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina</b>: 329<br /><br />Johnson JL, Cusack B, Davies MP, Fauq A, Rosenberry TL (2003) <br />Unmasking tandem site interaction in human acetylcholinesterase. Substrate activation with a cationic acetanilide substrate<br /><i>Biochemistry</i> <b>42</b>: 5438<br /><br />Johnson JL, Cusack B, Hughes TF, McCullough EH, Fauq A, Romanovskis P, Spatola AF, Rosenberry TL (2003) <br />Inhibitors tethered near the acetylcholinesterase active site serve as molecular rulers of the peripheral and acylation sites<br /><i>Journal of Biological Chemistry</i> <b>278</b>: 38948<br /><br />Braselton WE, Johnson JL, Carlson MP, Schneider NR (2000) <br />Gas chromatography/mass spectrometry identification and quantification of isazophos in a famphur pour-on and in bovine tissues after a toxic exposure<br /><i>J Vet Diagn Invest</i> <b>12</b>: 15<br /><br />